Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Pangaea Logistics
PANL
$498M
| $654K | ﹤0.01% |
96,572
+83,274
| +626% | +$514K |
|
|
TUYA
2927
Tuya Inc
TUYA
$1.03B
| $651K | ﹤0.01% |
344,385
-4,851
| -1% | -$9.32K |
|
2928
Willdan Group
WLDN
$1.04B
| $649K | ﹤0.01% |
33,889
+959
| +3% | +$16.1K |
|
2929
Woodside Energy
WDS
$44.6B
| $645K | ﹤0.01% |
+27,807
| New | +$637K |
|
2930
MVB Financial
MVBF
$397M
| $644K | ﹤0.01% |
30,555
+2,878
| +10% | +$54.1K |
|
|
DFTX
2931
Definium Therapeutics
DFTX
$5.78B
| $642K | ﹤0.01% |
179,809
+859
| +0.5% | +$2.96K |
|
2932
OptimizeRx
OPRX
$114M
| $642K | ﹤0.01% |
44,903
-6
| -0% | -$85 |
|
2933
Intrepid Potash
IPI
$456M
| $641K | ﹤0.01% |
28,263
-1,281
| -4% | -$29K |
|
|
CSTR
2934
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $641K | ﹤0.01% |
52,203
-2,059
| -4% | -$27.3K |
|
2935
Rimini Street
RMNI
$445M
| $639K | ﹤0.01% |
133,392
+683
| +0.5% | +$2.83K |
|
2936
Red River Bancshares
RRBI
$662M
| $638K | ﹤0.01% |
12,991
+1,160
| +10% | +$56.7K |
|
2937
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $638K | ﹤0.01% |
6,200
+3,008
| +94% | +$313K |
|
|
CARM
2938
DELISTED
Carisma Therapeutics
CARM
| $638K | ﹤0.01% |
+72,743
| New | +$396K |
|
2939
Limbach Holdings
LMB
$855M
| $636K | ﹤0.01% |
+25,729
| New | +$518K |
|
2940
Sierra Bancorp
BSRR
$528M
| $636K | ﹤0.01% |
37,488
+395
| +1% | +$6.5K |
|
2941
C4 Therapeutics
CCCC
$385M
| $635K | ﹤0.01% |
231,034
-85,975
| -27% | -$276K |
|
2942
Legacy Housing
LEGH
$625M
| $634K | ﹤0.01% |
27,329
+4,526
| +20% | +$98K |
|
2943
Red Violet
RDVT
$979M
| $633K | ﹤0.01% |
30,772
+3,232
| +12% | +$60.3K |
|
2944
First Bancorp
FNLC
$396M
| $632K | ﹤0.01% |
25,964
-18
| -0.1% | -$444 |
|
2945
Aveanna Healthcare
AVAH
$2.04B
| $630K | ﹤0.01% |
372,602
+19,965
| +6% | +$25K |
|
|
CMAX
2946
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $630K | ﹤0.01% |
6,748
+1,298
| +24% | +$114K |
|
|
SRTA
2947
Strata Critical Medical Inc
SRTA
$434M
| $629K | ﹤0.01% |
159,744
+1,632
| +1% | +$5.18K |
|
2948
X4 Pharmaceuticals
XFOR
$375M
| $628K | ﹤0.01% |
10,795
+9,382
| +664% | +$482K |
|
|
PBPB
2949
DELISTED
Potbelly
PBPB
| $627K | ﹤0.01% |
71,357
+59,667
| +510% | +$524K |
|
2950
EyePoint Inc
EYPT
$1.03B
| $622K | ﹤0.01% |
71,548
+266
| +0.4% | +$1.62K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.